PinthusJH,WitkosM,FleshnerNE,SweetJ,EvansA,JewettMA, 2006.Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome,J Urol 176 979 -84
ArslanE,OzcelikF,DemirbasS., 2013.Cancer types related to obesity,Anatol J Clin Investig 7 176 -84
WilsonKM,GiovannucciEL,MucciLA, 2012.Lifestyle and dietary factors in the prevention of lethal prostate cancer,Asian J Androl 14 365 -74
CalleEE,Kaaks R, 2004.Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms,Nat Rev Cancer 4 579 -91
RobertsDL,DiveC,RenehanAG, 2010.Biological mechanisms linking obesity and cancer risk: new perspectives,Annu Rev Med 61 301 -16
KhandekarMJ,CohenP,SpiegelmanBM, 2011.Molecular mechanisms of cancer development in obesity,Nat Rev Cancer 11 886 -95
BaillargeonJ,PlatzEA,RoseDP,PollockBH,AnkerstDP,HaffnerS, 2006.Obesity, adipokines, and prostate cancer in a prospective population-based study,Cancer Epidemiol Biomarkers Prev 15 1331 -5
EngelandA,TretliS,BjørgeT, 2003.body mass index, and prostate cancer: a follow-up of 950000 Norwegian men,Br J Cancer 89 1237 -42
AnderssonSO,WolkA,BergstromR,AdamiHO,EngholmG,EnglundA, 1997.Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers,J Natl Cancer Inst 89 385 -9
WrightME,ChangSC,SchatzkinA,AlbanesD,KipnisV,MouwT, 2007.Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality,Cancer 109 675 -84
RodriguezC,FreedlandSJ,DekaA,JacobsEJ,McCulloughML,PatelAV, 2007.Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort,Cancer Epidemiol Biomarkers Prev 16 63 -9
MajorJM,Klonoff-CohenHS,PierceJP,SlymenDJ,SaltzsteinSL,MaceraCA, 2011.Prostate cancer postoperative nomogram scores and obesity,PLoS One 6 e17382 -
ZhangX,ZhouG,SunB,ZhaoG,LiuD,SunJ, 2015.Impact of obesity upon prostate cancer-associated mortality: A metaanalysis of 17 cohort studies,Oncol Lett 9 1307 -12
MaJ,LiH,GiovannucciE,MucciL,QiuW,NguyenPL, 2008.Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis,Lancet Oncology 9 1039 -47
VidalAC,HowardLE,MoreiraDM,Castro-SantamariaR,AndrioleGL, 2014.Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study,Cancer Epidemiol Biomarkers Prev 23 2936 -42
DiscacciatiA,OrsiniN,WolkA, 2012.Body mass index and incidence of localized and advanced prostate cancer - a doseresponse meta-analysis of prospective studies,Ann Oncol 23 1665 -71
FreedlandSJ,IsaacsWB,MangoldLA,YiuSK,GrubbKA,PartinAW, 2005.Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years,Clin Cancer Res 11 2883 -8
KaneCJ,BassettWW,SadetskyN,SilvaS,WallaceK,PastaDJ, 2005.Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE,J Urol 173 732 -6
IremashviliV,SolowayMS,RosenbergDL,ManoharanM., 2012.Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance,J Urol 187 1594 -9
BanezLL,HamiltonRJ,PartinAW,VollmerRT,SunL,RodriguezC, 2007.Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer,J Am Med Assoc 298 2275 -80
EfstathiouJA,ChenMH,RenshawAA,LoffredoMJ,D, 2007.Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer,Cancer 109 1493 -8
de CobelliO,TerraccianoD,TagliabueE,RaimondiS,GalassoG,CioffiA, 2015.Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance,Urol Oncol 33 201 -8
TruongM,SlezakJA,LinCP,IremashviliV,SadoM,RazmariaAA, 2013.Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer,Cancer 119 3992 -4002
HeB,ChenR,GaoX,RenS,YangB,HouJ, 2016.Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation,Oncotarget 7 17275 -85
PloussardG,de la TailleA,BayoudY,DurandX,TerryS,XylinasE, 2012.The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance,Eur Urol 61 356 -62